Skip to product information
1 of 1

Abbott Rapid Dx North America LLC

HbA1c Test Kit Afinion HbA1c Dx HbA1c Test 15 Tests CLIA Non-Waived

PRODUCT HIGHLIGHTS

  • CLIA Non-Waived – Moderate Complexity

  • 15 test cartridges included

  • Delivers results in 3 minutes

  • Aids in diagnosis of diabetes and risk identification
  • Fast Delivery
  • Auto Delivery , Free Shipping For $100 Above Products
Item Description Quantity Price
1116794
TEST KIT, HEMOGLOBIN A1C DX MOD COMPLEX
Special order from supplier. Approximate delivery is 2-4 weeks.
This Item is non-returnable & non-refundable
Box of 15

List Price:$253.99

Price:$245.99

You save $8.00

Add To Cart
View full details

Description

The Afinion HbA1c Dx Test Kit by Abbott Rapid Dx is designed for use with the Afinion 2 Analyzer to provide fast, accurate HbA1c results. This CLIA Moderate Complexity test offers reliable diabetes diagnostic support with results in just 3 minutes.

Each kit includes 15 HbA1c Dx test cartridges, containing all necessary reagents for the quantitative measurement of glycated hemoglobin (% HbA1c) in venous and capillary whole blood samples. The cartridges allow for 3 months of room temperature storage, making them convenient for laboratory and clinical use.

✅ CLIA Non-Waived – Moderate Complexity
✅ 15 test cartridges included
✅ Delivers results in 3 minutes
✅ Aids in diagnosis of diabetes and risk identification
✅ For use with Afinion 2 Analyzer
✅ Requires refrigeration for long-term storage

Specifications:

  • Manufacturer #: 1116794

  • Brand: Afinion HbA1c Dx

  • Manufacturer: Abbott Rapid Dx North America LLC

  • Application: HbA1c Test Kit

  • CLIA Classification: Moderate Complexity, Non-Waived

  • Number of Tests: 15

  • Sample Type: Whole Blood

  • Format: Cartridge

  • Test Type: Diabetes Management / Diagnostic Aid

  • Storage: Refrigerated (room temp stable for 3 months)

  • Time to Results: 3 minutes

  • UNSPSC Code: 41116104

This kit is an in vitro diagnostic test intended as an aid in the diagnosis of diabetes and in identifying patients who may be at risk of developing the condition.